Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Viemed Healthcare (VMD) Other Working Capital Changes (2018 - 2025)

Historic Other Working Capital Changes for Viemed Healthcare (VMD) over the last 8 years, with Q3 2025 value amounting to $127000.0.

  • Viemed Healthcare's Other Working Capital Changes fell 9368.79% to $127000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$407000.0, marking a year-over-year increase of 1761.13%. This contributed to the annual value of -$544000.0 for FY2024, which is 7500.0% up from last year.
  • According to the latest figures from Q3 2025, Viemed Healthcare's Other Working Capital Changes is $127000.0, which was down 9368.79% from -$102000.0 recorded in Q2 2025.
  • Viemed Healthcare's Other Working Capital Changes' 5-year high stood at $2.2 million during Q3 2022, with a 5-year trough of -$1.9 million in Q4 2021.
  • In the last 5 years, Viemed Healthcare's Other Working Capital Changes had a median value of $127000.0 in 2025 and averaged $57263.2.
  • Its Other Working Capital Changes has fluctuated over the past 5 years, first tumbled by 297187.5% in 2023, then soared by 62260.87% in 2025.
  • Viemed Healthcare's Other Working Capital Changes (Quarter) stood at -$1.9 million in 2021, then surged by 98.33% to -$32000.0 in 2022, then plummeted by 2971.88% to -$983000.0 in 2023, then dropped by 5.09% to -$1.0 million in 2024, then skyrocketed by 112.29% to $127000.0 in 2025.
  • Its Other Working Capital Changes stands at $127000.0 for Q3 2025, versus -$102000.0 for Q2 2025 and $601000.0 for Q1 2025.